Marathon Asset Management LTD Royalty Pharma PLC Transaction History

Marathon Asset Management LTD

$2.49 Billion
Q3 2025

A detailed history of Marathon Asset Management LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Marathon Asset Management LTD holds 426,072 shares of RPRX stock, worth $15.5 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

426,072

Previous 579,621 26.49%

Holding current value

$15.5 Million

Previous $20.9 Million 28.02%

% of portfolio

0.6%

Previous 0.74%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 17, 2025	SELL	$34.9 - $37.91 $5.36 Million - $5.82 Million	-153,549 Reduced 26.49%	426,072 $15 Million
Q2 2025 Aug 11, 2025	SELL	$30.85 - $36.14 $2.06 Million - $2.41 Million	-66,625 Reduced 10.31%	579,621 $20.9 Million
Q1 2025 Apr 24, 2025	SELL	$25.75 - $33.86 $1.77 Million - $2.33 Million	-68,924 Reduced 9.64%	646,246 $20.1 Million
Q4 2024 Feb 06, 2025	SELL	$24.28 - $28.39 $1.14 Million - $1.33 Million	-46,981 Reduced 6.16%	715,170 $18.2 Million
Q3 2024 Oct 17, 2024	BUY	$25.63 - $29.27 $472,207 - $539,270	18,424 Added 2.48%	762,151 $21.6 Million
Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $1.28 Million - $1.46 Million	-48,680 Reduced 6.14%	743,727 $19.6 Million
Q1 2024 May 14, 2024	SELL	$27.46 - $31.33 $1.65 Million - $1.88 Million	-60,011 Reduced 7.04%	792,407 $24.1 Million
Q4 2023 Feb 12, 2024	BUY	$26.21 - $29.22 $2.27 Million - $2.53 Million	86,585 Added 11.31%	852,418 $23.9 Million
Q3 2023 Nov 06, 2023	SELL	$26.26 - $31.38 $980,390 - $1.17 Million	-37,334 Reduced 4.65%	765,833 $20.8 Million
Q2 2023 Aug 04, 2023	SELL	$29.6 - $36.56 $2.66 Million - $3.29 Million	-90,025 Reduced 10.08%	803,167 $24.7 Million
Q1 2023 May 03, 2023	SELL	$32.77 - $39.4 $4.52 Million - $5.44 Million	-138,077 Reduced 13.39%	893,192 $32.2 Million
Q4 2022 Feb 07, 2023	SELL	$39.17 - $44.04 $1.66 Million - $1.87 Million	-42,476 Reduced 3.96%	1,031,269 $40.8 Million
Q3 2022 Oct 25, 2022	SELL	$39.88 - $44.65 $35.6 Million - $39.8 Million	-891,591 Reduced 45.37%	1,073,745 $43.1 Million
Q2 2022 Aug 01, 2022	SELL	$37.53 - $44.22 $4.18 Million - $4.93 Million	-111,392 Reduced 5.36%	1,965,336 $82.6 Million
Q1 2022 Apr 21, 2022	SELL	$37.46 - $42.44 $6.2 Million - $7.03 Million	-165,602 Reduced 7.39%	2,076,728 $80.9 Million
Q4 2021 Jan 28, 2022	BUY	$35.17 - $42.48 $78.9 Million - $95.3 Million	2,242,330 New	2,242,330 $89.4 Million

Others Institutions Holding RPRX

# of Institutions

497

Shares Held

307M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Asset Management LTD with notifications on news.

Account

Marathon Asset Management LTD Royalty Pharma PLC Transaction History